Browse Diagnostic reagents industry topic

Product development subtopic

Articles 1-54 out of 54 article(s) Title Author Type Date Words NeoPharm Presents the Phase I Data for Patients with Metastatic Solid Tumors. Nov 17, 2009 776 NeoPharm Submits Application for a Multicenter, Open-Label, Phase II Study of LE-DT for Locally Advanced or Metastatic Pancreatic Cancer Patients as a Frontline Treatment. Oct 27, 2009 625 NeoPharm Submits Application for a Multicenter, Open-Label, Phase II Study of LE-DT for Castrate Resistant Prostate Cancer. Feb 11, 2009 605 Biothera Expands Metastatic Colorectal Cancer Trial. Jan 29, 2009 458 Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment. Clinical report Nov 19, 2008 1228 Phase 2 Study of IMC-1121B in First-Line Treatment of Advanced Non-Small Cell Lung Cancer Commences Patient Enrollment. Report Nov 11, 2008 662 Biothera Completes Enrollment of First Arm of Metastatic Colorectal Cancer Trial. Oct 7, 2008 364 Phase 2 Study of IMC-1121B for Advanced Ovarian Cancer Commences Patient Enrollment. Sep 30, 2008 716 United States: ImClone says begins Patient Enrollment for Phase 2 Study of IMC-A12 for Advanced Breast Cancer. Clinical report Sep 26, 2008 180 Randomized Phase 2 Study of IMC-A12 for Advanced Breast Cancer Commences Patient Enrollment. Clinical report Sep 25, 2008 780 Randomized Phase 2 Study of IMC-A12 and IMC-1121B for Advanced Prostate Cancer Commences Patient Enrollment. Clinical report Aug 26, 2008 872 United States: ImClone Systems initiates Phase 3 Clinical Trial of IMC-1121B antibody in Metastatic Breast Cancer. Aug 14, 2008 145 Global Phase 3 Study of IMC-1121B in Metastatic Breast Cancer Commences. Aug 13, 2008 1078 Phase 2 Study Of IMC-A12 for Advanced Soft Tissue Sarcoma Opens for Patient Enrollment. Jul 7, 2008 770 IMC-A12 Plus Temsirolimus Clinical Trial for Advanced Cancer Opens for Patient Enrollment. Jun 25, 2008 1173 ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer. Clinical report May 31, 2008 2583 NeoPharm Enrolls First Patient in Phase I Trial for Patients with Metastatic Solid Cancer. May 21, 2008 819 Phase I/II Studies of IMC-A12 in Pancreatic Cancer Open for Patient Enrollment. May 20, 2008 1092 United States: Phase II study of IMC-A12 for advanced Liver Cancer opens for Patient Enrollment. Report May 15, 2008 213 Phase II Study of IMC-A12 for Advanced Liver Cancer Opens for Patient Enrollment. Report May 13, 2008 1018 ImClone Announces Agreement with FDA on Special Protocol Assessment for Phase III Study of IMC-1121B in Breast Cancer. Apr 22, 2008 1047 NeoPharm Enrolls First Patients in Phase II Metastatic Breast Cancer Study. Mar 31, 2008 769 Phase I/II Studies of IMC-A12 in Pediatric Cancer Patients Commence Enrollment. Mar 5, 2008 1019 Phase II Study of IMC-1121B for Advanced Liver Cancer Commences Patient Enrollment. Feb 22, 2008 789 NEOPHARM Announces IND Filing for Novel Liposomal Delivery System of Docetaxel. Jan 2, 2008 584 Phase II Study of IMC-1121B for Advanced Malignant Melanoma Commences Patient Enrollment. Clinical report Dec 13, 2007 658 New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer. Nov 14, 2007 1933 Biothera Initiates Phase Ib/IIa Clinical Trial with Imprime PGG and Erbitux in Metastatic Colorectal Cancer Patients. Oct 9, 2007 336 Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports Use as a Single Agent in Patients with Advanced Colorectal Cancer. Oct 3, 2007 1650 ImClone Systems Expands IMC-A12 Development with Ten New Planned Clinical Trials. Sep 20, 2007 689 Phase II Study of IMC-A12 for Advanced Prostate Cancer Commences Patient Enrollment. Aug 29, 2007 546 Phase II Study of IMC-1121B for Advanced Renal Cell Cancer Opens for Patient Enrollment. Aug 24, 2007 564 Phase II Study of IMC-11F8 for Advanced Colorectal Cancer Has Commenced Patient Enrollment in Europe. Aug 9, 2007 536 Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO. Jun 5, 2007 680 Detect fungal infection. Brief article May 1, 2007 69 Randomized Phase III Trial Showed ERBITUX Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients. Clinical report Apr 16, 2007 2452 ImClone Systems Opts-out of Development Agreement with UCB to Focus Resources on Proprietary, Anti-VEGFr-2 Antibody IMC-1121B. Feb 6, 2007 548 Imclone Systems Commences Patient Treatment in U.S. Phase I Clinical Trial of IMC-3G3. Disease/Disorder overview Jan 3, 2007 560 NEOPHARM Announces Efficacy Results for Phase 3 PRECISE Trial. Dec 11, 2006 561 NEOPHARM Announces Presentation of Final Safety Data from Phase 1 Trial of CINTREDEKIN BESUDOTOX for Newly Diagnosed Malignant Glioma. Nov 20, 2006 1282 NEOPHARM Presents Updated CINTREDEKIN BESUDOTOX Phase I/II Median Survival Data at European Association of Neuro-Oncology (EANO) Meeting. Sep 18, 2006 1819 Coagulation factor X assay. Brief Article Dec 1, 2004 66 FDA approves expanded use of HPV test. (News). May 1, 2003 463 Trials begin for Alzheimer's diagnostic test. Brief Article Apr 1, 2000 72 CTI SUBMITS SECOND MODULE TO FDA FOR CANCER DETECTION SYSTEM. Statistical Data Included Mar 1, 2000 268 United Biomedical Inc. Monoclonal Antibody Prevents HIV Infection in Chimpanzees. Oct 9, 1998 505 Hemagen Obtains Clearance to Market Two Reagents to Evaluate Cardiovascular Risk. Oct 9, 1997 310 North American Scientific Inc. announces FDA approval for prostate cancer therapeutic device. Feb 19, 1997 227 Boston Probes begins operations; Will develop diagnostics using unique technology. Sep 26, 1996 409 Neoprobe files product marketing application for surgical cancer product with European authorities. May 30, 1996 693 Synbiotics Corp. receives USDA approval for room temperature storage of ICT GOLD HW diagnostic; new storage saves time, money and shelf space. May 2, 1996 245 Resolution Pharmaceuticals begins clinical trials on inflammation imaging agent. Oct 16, 1995 326 FDA panel recommends approval of application for first test to detect risk of preterm delivery. Apr 6, 1995 697 Xillix concludes multicenter clinical trial for LIFE-Lung. Mar 2, 1995 358